Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
Primary Purpose
Visceral Artery Aneurysms, Arteriovenous Malformations
Status
Withdrawn
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Penumbra Ruby Coil System
Sponsored by
About this trial
This is an interventional treatment trial for Visceral Artery Aneurysms focused on measuring visceral artery aneurysms, arteriovenous malformations, Penumbra Ruby Coil System
Eligibility Criteria
Inclusion Criteria:
- Patients enrolled in this study must be those treated according to the cleared indication for the Penumbra Ruby Coil System for visceral arterial and venous embolizations.
Exclusion Criteria:
- Patients in whom endovascular embolization therapies other than Penumbra Coils are used will be excluded from this study.
Sites / Locations
- Medical College of Wisconsin
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Penumbra Ruby Coil System
Arm Description
Outcomes
Primary Outcome Measures
1. Packing density with the number of coils implanted
2. Time of fluoroscopic exposure
3. Procedural device-related serious adverse events at immediate post-procedure
4. Occlusion of the aneurysm sac or target vessel at immediate post-procedure
5. Occlusion of the aneurysm sac or target vessel at one year post-procedure
Secondary Outcome Measures
1. Recanalization of the aneurysm sac or target vessel at 4 months post-procedure
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02079818
Brief Title
Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
Official Title
CLP 7463: Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Withdrawn
Why Stopped
The study was never initiated.
Study Start Date
June 2017 (Anticipated)
Primary Completion Date
September 2018 (Anticipated)
Study Completion Date
September 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Penumbra Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this study is to gather post market data on the Penumbra Ruby Coil System in the treatment of visceral artery aneurysms and arteriovenous malformations. This study is a prospective, multi-center study of patients with visceral artery aneurysms and visceral arteriovenous malformations who are treated by the Penumbra Ruby Coil System. Data for each patient are collected up to 12 months post-procedure for the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Visceral Artery Aneurysms, Arteriovenous Malformations
Keywords
visceral artery aneurysms, arteriovenous malformations, Penumbra Ruby Coil System
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Penumbra Ruby Coil System
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Penumbra Ruby Coil System
Intervention Description
The Penumbra Ruby™ Coil is a new generation of detachable coils developed by Penumbra Inc. This coil system is specifically designed for the occlusion of aneurysms and vessels that is equivalent to standard platinum coils. This system consists of: an implantable Coil attached to a Detachment Pusher as well as a Detachment Handle. The Detachment Pusher is comprised of a shaft with a radiopaque positioning marker, a Distal Detachment Tip, and a pull wire. The Detachment Handle is used to detach the Coil Implant from the Detachment Pusher. The Penumbra Ruby Coil is designed for endovascular embolization in the peripheral vasculature. Intended users for this device are physicians who have received appropriate training in interventional radiology and endovascular intervention.
Primary Outcome Measure Information:
Title
1. Packing density with the number of coils implanted
Time Frame
During the procedure
Title
2. Time of fluoroscopic exposure
Time Frame
During the procedure
Title
3. Procedural device-related serious adverse events at immediate post-procedure
Time Frame
At immediate post-procedure
Title
4. Occlusion of the aneurysm sac or target vessel at immediate post-procedure
Time Frame
At immediate post-procedure
Title
5. Occlusion of the aneurysm sac or target vessel at one year post-procedure
Time Frame
One year post-procedure
Secondary Outcome Measure Information:
Title
1. Recanalization of the aneurysm sac or target vessel at 4 months post-procedure
Time Frame
4 months post-procedure
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients enrolled in this study must be those treated according to the cleared indication for the Penumbra Ruby Coil System for visceral arterial and venous embolizations.
Exclusion Criteria:
Patients in whom endovascular embolization therapies other than Penumbra Coils are used will be excluded from this study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paraq J Patel, MD
Organizational Affiliation
Medical College of Wisconsin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical College of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
We'll reach out to this number within 24 hrs